OBD presents results of immunotherapy studies at FNIH Biomarker Consortium Cancer Steering Committee’s annual … – News-Medical.net
|
OBD presents results of immunotherapy studies at FNIH Biomarker Consortium Cancer Steering Committee's annual …
News-Medical.net Oxford BioDynamics Plc, a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, presented its latest results at the … |
